Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Mouse Lung
100%
Edema Formation
100%
Neurokinin B
100%
Tachykinin Receptors
100%
Receptor-independent
100%
Plasma Extravasation
72%
Lung
36%
Knock-in Mouse Model
36%
NK1 Receptor
27%
Liver
18%
Wild Mice
18%
Preeclampsia
18%
Receptor Knockout
18%
Tachykinin
18%
Intravenous Administration
9%
Substance P
9%
Pathway-specific
9%
Hypertension
9%
Endothelial Nitric Oxide Synthase (eNOS)
9%
Albumin
9%
Extravascular
9%
Indomethacin
9%
Nitroarginine
9%
Receptor Antagonist
9%
Independent Pathway
9%
Uterus
9%
Partial Inhibition
9%
Cyclooxygenase Inhibitors
9%
NK3 Receptor Antagonist
9%
Methyl Ester
9%
SR142801
9%
Neurokinin-1 Receptor (NK1R)
9%
Tachykinin NK1 Receptor
9%
NK2 Receptor
9%
Skin Edema
9%
Tissue Edema
9%
Dose-dependent
9%
Pharmacology, Toxicology and Pharmaceutical Science
Edema
100%
Tachykinin Receptor
100%
Neurokinin B
100%
Extravasation
72%
Receptor
36%
Knockout Mouse
36%
Tachykinin
27%
Preeclampsia
18%
Wild Type Mouse
18%
Receptor Antagonist
18%
Endothelial Nitric Oxide Synthase
9%
Indometacin
9%
N(g) Nitroarginine
9%
Substance P
9%
Iodine-125
9%
Prostaglandin Synthase Inhibitor
9%
Arginine Methyl Ester
9%
Osanetant
9%
Saredutant
9%
Skin Edema
9%
Diseases
9%
Hypertension
9%
Albumin
9%